1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → N-(2,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-2,6-difluoro-3-(propylsulfonamido)benzamide

HRID 2196721Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2196721
[CH3:1][C:2]1[NH:11][C:5]2=[N:6][CH:7]=[C:8]([NH2:10])[CH:9]=[C:4]2[C:3]=1[CH3:12].[F:13][C:14]1[C:22]([NH:23][S:24]([CH2:27][CH2:28][CH3:29])(=[O:26])=[O:25])=[CH:21][CH:20]=[C:19]([F:30])[C:15]=1[C:16](O)=[O:17].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>CN(C=O)C>[CH3:1][C:2]1[NH:11][C:5]2=[N:6][CH:7]=[C:8]([NH:10][C:16](=[O:17])[C:15]3[C:19]([F:30])=[CH:20][CH:21]=[C:22]([NH:23][S:24]([CH2:27][CH2:28][CH3:29])(=[O:26])=[O:25])[C:14]=3[F:13])[CH:9]=[C:4]2[C:3]=1[CH3:12]

Komponenten

6

Versuchsvorschrift

2,3-Dimethyl-1H-pyrrolo[2,3-b]pyridin-5-amine (0.048 g, 0.298 mmol), 2,6-difluoro-3-(3-propylsulfonamido)benzoic acid (0.092 g, 0.328 mmol), EDCI (0.063 g, 0.328 mmol) and HOBt (0.040 g, 0.298 mmol) were dissolved in DMF (1.6 mL) and stirred at room temperature for 16 hours. The reaction mixture was directly purified by reverse phase HPLC to give N-(2,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-2,6-difluoro-3-(propylsulfonamido)benzamide (0.059 g, 47%) as a solid. 1H NMR (400 MHz, d6-DMSO) 11.23 (s, 1H), 10.77 (s, 1H), 9.19 (br s, 1H), 8.27-8.09 (m, 2H), 7.59-7.39 (m, 1H), 7.28-7.10 (m, 1H), 3.17-2.95 (m, 2H), 2.32 (s, 3H), 2.15 (s, 3H), 1.84-1.65 (m, 2H), 0.98 (s, 3H); m/z (ES-MS) 423.2 (96.1%) [M+1].

Aufarbeitung

  1. customThe reaction mixture was directly purified by reverse phase HPLC

Quellen und Nachweise

ORD-Eintrag
ord-4c6b9293e7504e0197043d56e2a0b796
Quelldatensatz
uspto-grants-2012_12
Patentnummer
US08338452B2

Notizen zur Reaktion

Wird geladen…